These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1811989)

  • 1. Competitive inhibition of human placental aromatase by N-n-octanoylnornicotine and other nornicotine derivatives.
    Bullion K; Ohnishi S; Osawa Y
    Endocr Res; 1991; 17(3-4):409-19. PubMed ID: 1811989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco alkaloid derivatives as inhibitors of breast cancer aromatase.
    Kadohama N; Shintani K; Osawa Y
    Cancer Lett; 1993 Dec; 75(3):175-82. PubMed ID: 8313352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT; Vickery LE
    Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive product inhibition of aromatase by natural estrogens.
    Shimizu Y; Yarborough C; Osawa Y
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):651-6. PubMed ID: 8476777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible inhibition of human placental microsomal aromatase by CGS 18320B and other non-steroidal compounds.
    Bullion KA; Osawa Y; Braun DG
    Endocr Res; 1990; 16(2):255-67. PubMed ID: 2140551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human placental microsomal aromatase by thyroid hormone and iodothyronine derivatives.
    Bullion K; Osawa Y
    Endocr Res; 1988; 14(1):21-33. PubMed ID: 3391136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of reversible inhibition of 16alpha-hydroxyandrostenedione aromatization in human placental microsomes by suicide substrates of androstenedione aromatization.
    Numazawa M; Mutsumi A; Tachibana M; Yoshimura A
    Biol Pharm Bull; 2003 Jun; 26(6):890-2. PubMed ID: 12808307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological characterization of A-ring steroids.
    Johnston JO; Wright CL; Burkhart JP; Peet NP
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):623-31. PubMed ID: 8476773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate specificity of the placental microsomal aromatase.
    Gibb W; Lavoie JC
    Steroids; 1980 Nov; 36(5):507-19. PubMed ID: 7456098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active-site-directed inactivation of aromatase from human placental microsomes by brominated androgen derivatives.
    Bellino FL; Gilani SS; Eng SS; Osawa Y; Duax WL
    Biochemistry; 1976 Oct; 15(21):4730-6. PubMed ID: 974087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereochemistry of the functional group determines the mechanism of aromatase inhibition by 6-bromoandrostenedione.
    Osawa Y; Osawa Y; Coon MJ
    Endocrinology; 1987 Sep; 121(3):1010-6. PubMed ID: 3622372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple functions of aromatase and the active site structure; aromatase is the placental estrogen 2-hydroxylase.
    Osawa Y; Higashiyama T; Shimizu Y; Yarborough C
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):469-80. PubMed ID: 8476762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro.
    Barbieri RL; Gochberg J; Ryan KJ
    J Clin Invest; 1986 Jun; 77(6):1727-33. PubMed ID: 3711333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroperoxides as inactivators of aromatase: 10 beta-hydroperoxy-4-estrene-3,17-dione, crystal structure and inactivation characteristics.
    Covey DF; Hood WF; Beusen DD; Carrell HL
    Biochemistry; 1984 Nov; 23(23):5398-406. PubMed ID: 6509027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
    Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
    J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatase inhibition by flavonoids.
    Ibrahim AR; Abul-Hajj YJ
    J Steroid Biochem Mol Biol; 1990 Oct; 37(2):257-60. PubMed ID: 2268557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione.
    Abul-Hajj YJ; Liu XP; Hedge M
    Steroids; 1995 May; 60(5):423-7. PubMed ID: 7570717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent aromatase inactivation by 4 beta,5 beta-epoxides of the natural substrate androstenedione and its 19-oxygenated analogs.
    Numazawa M; Yoshimura A; Tachibana M; Shelangouski M; Ishikawa M
    Steroids; 2002 Mar; 67(3-4):185-93. PubMed ID: 11856542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase inhibition by 4-thiosubstituted-4-androstene-3,17-dione derivatives.
    Abul-Hajj YJ
    J Steroid Biochem; 1990 Jan; 35(1):139-43. PubMed ID: 2308324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovine placental aromatase: studies of activity levels, kinetic characteristics and effects of aromatase inhibitors.
    France JT; Mason JI; Magness RR; Murry BA; Rosenfeld CR
    J Steroid Biochem; 1987 Aug; 28(2):155-60. PubMed ID: 3626552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.